Synopsis

There are a multitude of reasons for which neuromodulation devices must occasionally be removed or explanted from a patient. Unfortunately, this process often leads to fractured leads and/or fragments of leads left in the patient, due to limiting design features of current technologies. Here we demonstrate a reliable procedure by which an injectable helical wire structure electrode (Injectrode) may be removed easily, quickly, completely, and robustly from benchtop phantom and preclinical models.

Disclosures

Manfred Franke is employed by and has equity in Neuronoff, Inc.
Amelia Howe is employed by and has equity in Neuronoff, Inc.
Stephan Nieuwoudt is employed by and has equity in Neuronoff, Inc.
Emily Szabo is employed by and has equity in Neuronoff, Inc.
Jacob Conard is employed by Neuronoff, Inc.
Morgan McGaughey is employed by and has equity in Neuronoff, Inc.
Derrick Liu is employed by and has equity in Neuronoff, Inc.
Shaher Ahmad is employed by and has equity in Neuronoff, Inc.
Kip A. Ludwig is receiving funding and has equity in Neuronoff, Inc.
Amol Soin has equity in Neuronoff, Inc.
Alaa Abd-Elsayed has equity in Neuronoff, Inc.
Andrew J. Shoffstall is receiving funding and has equity in Neuronoff, Inc.
This project is supported by Neuronoff Inc., NIH 1U18EB029251-01 Grant, and the DARPA EEI program. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense or the National Institutes of Health